---
title: "Praxis Precision Medicines makes equity investment in Remagine Labs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291928955.md"
description: "Praxis Precision Medicines made an equity investment in Remagine Labs to accelerate collaboration on transdermal ulixacaltamide for essential tremor. This deal supports the development of an iontophoretic patch, expanding beyond the oral program. Ulixacaltamide’s NDA is under FDA review with a PDUFA date of Jan. 29, 2027."
datetime: "2026-07-07T12:03:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291928955.md)
  - [en](https://longbridge.com/en/news/291928955.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291928955.md)
---

# Praxis Precision Medicines makes equity investment in Remagine Labs

-   Praxis Precision Medicines made an equity investment in Remagine Labs to accelerate a collaboration on transdermal ulixacaltamide for essential tremor. \* The deal supports development of an iontophoretic patch, positioning ulixacaltamide beyond the company’s oral program. \* Ulixacaltamide’s essential tremor NDA is under FDA review, with a PDUFA target action date of Jan. 29, 2027. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Praxis Precision Medicines Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607070800PRIMZONEFULLFEED9757768) on July 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [PRAX.US](https://longbridge.com/en/quote/PRAX.US.md)

## Related News & Research

- [Praxis Precision Medicines (PRAX) Wins FDA Breakthrough Tag As CNS Pipeline Advances](https://longbridge.com/en/news/295313402.md)
- [Praxis Q2 2026 results: $1.4 billion liquidity supports runway into 2028](https://longbridge.com/en/news/295110125.md)
- [HeartBeam posts Q2 presentation outlining heart attack detection progress and initial commercial launch traction](https://longbridge.com/en/news/295840063.md)
- [12:15 ETInventHelp Inventor Develops Improved Stoma Wafer (OCC-1842)](https://longbridge.com/en/news/295824399.md)
- [08:04 ETGitKraken Introduces GitLens 19, Bringing Human and AI Workflows Together in One Workbench](https://longbridge.com/en/news/295931656.md)